PAWI-2 is a p53-Activator and Wnt Inhibitor. PAWI-2 inhibits beta3-KRAS signaling independent of KRAS. PAWI-2 selectively inhibits phosphorylation of TBK1. PAWI-2 activates apoptosis (activation of caspase-3/7), and induces PARP cleavage. PAWI-2 promotes optineurin translocation into the nucleus and causes G2/M arrest. PAWI-2 reverses cancer stemness and overcomes drug resistance in an integrin beta3 KRAS-dependent human pancreatic cancer stem cells (hPCSCs). PAWI-2 inhibits growth of tumors from hPCSCs in orthopic xenograft mice model[1][2].
Molecular Weight:
371.45
Purity:
99.29
CAS Number:
[1448427-02-8]
Formula:
C19H21N3O3S
Target:
Apoptosis,Caspase,IKK,MDM-2/p53,Wnt
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted